Retrospective Natural History Study of Retinitis Pigmentosa
PHENOROD1
Natural History Study of Retinitis Pigmentosa in Patient Carrying Pathogenic Mutations in RHO, PDE6A or PDE6B.
1 other identifier
observational
113
1 country
1
Brief Summary
This is natural history study of rods and cones degenerations in patients with Retinitis Pigmentosa (RP) caused by pathogenic mutations in RHO, PDE6A or PDE6B gene mutations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
June 4, 2019
CompletedFirst Posted
Study publicly available on registry
June 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedAugust 4, 2021
August 1, 2021
1 year
June 4, 2019
August 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Visual acuity
Progression of disease over time as measured by best corrected visual acuity (BCVA) (ETDRS, Snellen) and refraction
2 years
Visual field
Progression of disease over time as measured by visual fields (kinetic and static)
2 years
Spectral Domain Optical Coherence tomography (SD-OCT)
Progression of disease over time as measured by SD-OCT (EZ length, ELM length, ONL thickness, macular volume).
2 years
Fundus Autofluorescence (FAF)
Progression of disease as measured by FAF (Hyperautofluorescent ring)
2 years
Secondary Outcomes (5)
Patients characteristics
2 years
Clinical diagnosis
baseline (At diagnosis)
Genetic diagnosis
baseline (At diagnosis)
Electroretinogram (ERG)
baseline (At diagnosis)
Color vision
2 years
Eligibility Criteria
Subjects with RP caused by pathogenic mutations in RHO, PDE6A or PDE6B gene mutations.
You may qualify if:
- Patients with RP caused by pathogenic mutations in RHO, PDE6A or PDE6B genes.
You may not qualify if:
- Patients with a pathogenic mutation in any other gene known to be involved in RP.
- Patients with any ocular disorder other than RP, likely to impact the retinal function.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SparingVisionlead
Study Sites (1)
CHNO XV-XX Paris - CIC 1423
Paris, 75012, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2019
First Posted
June 5, 2019
Study Start
October 1, 2018
Primary Completion
October 1, 2019
Study Completion
September 30, 2021
Last Updated
August 4, 2021
Record last verified: 2021-08